Predicted mutational epitopes suitable for immunological cancer control
The approach consisted in quantifying somatic tumor mutations and any corresponding predicted, candidate epitopes that would be expected to be of utility in immunological cancer control. This allows, for the first time, estimation of the potential impact of preventative cancer vaccination.
René L. Warren and Robert A. Holt. 2010. A census of predicted mutational epitopes suitable for immunological cancer control. Human Immunology. 10.1016/j.humimm.2009.12.007. 71:245-254
Further details of this publication can be found online.